Health Care & Life Sciences » Biotechnology | Immuno-Biological Laboratories Co. Ltd.

Immuno-Biological Laboratories Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
670,428.00
729,030.00
717,661.00
741,525.00
758,286.00
Cost of Goods Sold (COGS) incl. D&A
336,092.00
403,599.00
287,382.00
348,721.00
281,308.00
Gross Income
334,336.00
325,431.00
430,279.00
392,804.00
476,978.00
SG&A Expense
442,221.00
506,948.00
505,632.00
1,549,736.00
525,769.00
EBIT
107,885.00
181,517.00
75,353.00
1,156,932.00
48,791.00
Unusual Expense
2,784.00
6,667.00
17,300.00
915,032.00
767.00
Non Operating Income/Expense
8,679.00
25,708.00
68,627.00
7,624.00
648.00
Interest Expense
2,252.00
2,639.00
5,775.00
9,307.00
1,804.00
Pretax Income
112,025.00
161,078.00
29,531.00
2,088,800.00
51,940.00
Income Tax
5,540.00
4,831.00
2,367.00
5,667.00
697.00
Consolidated Net Income
117,565.00
165,909.00
31,898.00
2,094,467.00
52,637.00
Net Income
114,693.00
158,480.00
31,898.00
2,094,467.00
52,637.00
Net Income After Extraordinaries
114,693.00
158,480.00
31,898.00
2,094,467.00
52,637.00
Net Income Available to Common
114,693.00
158,480.00
31,898.00
2,094,467.00
52,637.00
EPS (Basic)
17.99
24.21
4.86
287.53
7.01
Basic Shares Outstanding
6,372.10
6,547.10
6,563.80
7,284.40
7,506.80
EPS (Diluted)
18.00
24.21
4.86
287.53
7.01
Diluted Shares Outstanding
6,372.10
6,547.10
6,563.80
7,284.40
7,506.80
EBITDA
7,089.00
73,555.00
8,704.00
965,107.00
48,791.00
Non-Operating Interest Income
4,007.00
4,037.00
270.00
97.00
71.00
Minority Interest Expense
2,872.00
7,429.00
-
-
-

About Immuno-Biological Laboratories Co.

View Profile
Address
1091-1 Naka Aza-Higashida
Fujioka Gumma 375
Japan
Employees -
Website http://www.ibl-japan.co.jp
Updated 09/14/2018
Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.